I thought I had long COVID — but it was a 10-year-old tumor; Certain cancers will likely rise exponentially due to COVID-19 screening delays, and other C-Virus related stories
I thought I had long COVID — but it was a 10-year-old tumor;
A man from England thought that he was battling long COVID, but it turned out he actually had a brain tumor — which had been growing for 10 years.
Grant Churnin-Ritchie, 42, thought that his tiredness was due to the aftermath of coming down with the illness in July 2021.
“I kept going to my GP, who said I had long COVID,” Churnin-Ritchie explained to South West News Service. “This went on for several months, but I really didn’t feel well in myself and felt it was something more serious.”
“I was so tired and I was experiencing a tingling sensation in my arms.”
He felt like it wasn’t long COVID – and instead was something much more serious.
The dad of three finally got some blood work done and an ECG test, which revealed that his heartbeat was abnormal, according to SWNS.
Doctors also told him that he had something called adrenal insufficiency, which meant that his adrenal gland doesn’t make enough of certain hormones, and he was additionally diagnosed with hypothyroidism, an under-active thyroid gland. —>READ MORE HERE
Certain cancers will likely rise exponentially due to COVID-19 screening delays:
Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases that could have been caught earlier with screening, and may now be diagnosed at later stages, placing an increased burden on an already strained healthcare system, according to a new research article published in the Journal of the American College of Surgeons (JACS).
“While the medical system as a whole experienced an incredible burden from the COVID-19 pandemic, now we’re going to see a much different burden present itself due to delays in cancer screening,” said senior author Teviah E. Sachs, MD, MPH, FACS, an associate professor of surgery at Boston University Chobanian and Avedisian School of Medicine and chief of the section of surgical oncology at Boston Medical Center.
“With this study, we sought to illustrate with data how we could forecast these likely future trends related to screenable cancer incidence.”
For the study, researchers at Boston University developed a predictive statistical model to quantify missed diagnoses of lung, breast, and colorectal cancers by comparing observed cancer rates in 2020 with pre-pandemic cancer rates (2010-2019). According to the authors, the study is one of the first to look at the number of missed colon, lung, and breast cancer diagnoses at the U.S. population level, and adds to the growing body of scientific research revealing how pandemic-related disruptions constrained cancer care.
“These are all cancers that have very profound incidences in our patient population across the U.S. They are much better managed and often curable when found early, and devastating when caught late,” Dr. Sachs said. “In addition, these are all screening tests that were likely put off during COVID-19 because they require patients to come into the hospital setting.” —>READ MORE HERE
Follow links below to relevant/related stories and resources:
North Korea spent pandemic building border wall to stop defectors
NYPD struggles with post-pandemic wave of violence as major crime stays steady at higher rates
USA TODAY: Coronavirus Updates
YAHOO NEWS: Coronavirus Live Updates
NEW YORK POST: Coronavirus The Latest
If you like what you see, please “Like” and/or Follow us on FACEBOOK here, GETTR here, and TWITTER here.
Comments are closed.